Gregorio G V, Mowat A P
King's College Hospital, Department of Child Health, Denmark Hill, London, UK.
Pediatr Nephrol. 1994 Oct;8(5):610-9. doi: 10.1007/BF00858146.
Specific and sensitive diagnostic tests are now available to identify type A, B, C, D and E hepatitis. Hepatitis A and E which cause only acute, very rarely fulminant, hepatitis are spread largely by the faecal-oral route, having a brief viraemic phase. Hepatitis B, C and D which are transmitted parenterally and via secretions are often associated with chronic viraemia. Patients with chronic renal disease are at particular risk. Impaired immunity due to disease or drugs increases the propensity to develop a chronic carrier state which may progress to cirrhosis and hepatocellular carcinoma. Limited reports indicate that hepatitis C infection may cause cirrhosis more rapidly than hepatitis B. The emergence of mutants to both hepatitis B and C is a cause for concern. Treatment with interferon is of limited efficacy. Screening of blood products for viral markers and prudent handling of potentially infected materials to avoid contamination of damaged skin or mucous membrane are the best strategies to prevent infection. Hepatitis B vaccination of all newborns, young adolescents and those at risk is the most effective means of reducing the carrier frequency.
现在已有特异性和敏感性高的诊断检测方法来识别甲型、乙型、丙型、丁型和戊型肝炎。仅引起急性肝炎(极少为暴发性肝炎)的甲型和戊型肝炎主要通过粪-口途径传播,病毒血症期短暂。通过肠道外途径和分泌物传播的乙型、丙型和丁型肝炎常伴有慢性病毒血症。慢性肾病患者面临的风险尤其高。因疾病或药物导致的免疫功能受损会增加发展为慢性携带者状态的倾向,而这种状态可能会进展为肝硬化和肝细胞癌。有限的报告表明,丙型肝炎感染可能比乙型肝炎更快地导致肝硬化。乙型和丙型肝炎病毒变异体的出现令人担忧。干扰素治疗的疗效有限。筛查血液制品中的病毒标志物以及谨慎处理潜在感染材料以避免受损皮肤或黏膜受到污染是预防感染的最佳策略。对所有新生儿、青少年以及高危人群进行乙型肝炎疫苗接种是降低携带者频率的最有效方法。